Prezent Vivo receives recognition at the 2026 BioTech Breakthrough Awards

  • 0
  • 0 views

Communicating scientific findings accurately is a persistent challenge for life sciences companies, particularly as research becomes more complex and organizations need to translate clinical data into materials for different audiences. AI-powered technologies are emerging as tools to address this gap, combining automation with specialized expertise to improve how scientific information is communicated.

Prezent, founded by Rajat Mishra, develops AI-powered solutions designed to improve business communication. Its life sciences-focused offering, Prezent Vivo, has received recognition at the sixth annual BioTech Breakthrough Awards, a program highlighting technological advancements and innovation across the biotechnology industry.

Organized by BioTech Breakthrough, part of the Tech Breakthrough market intelligence and recognition organization, the awards evaluate companies, products, and services contributing to developments in biotechnology. Its annual program covers areas ranging from biopharmaceuticals and therapeutics to genomics, medical technology, data analytics, and artificial intelligence.

The selection process involves an independent panel of industry experts who assess submissions based on criteria such as innovation, performance, functionality, ease of use, value, and market impact. The recognition provides industry visibility for companies developing technologies aimed at addressing challenges across the life sciences sector.

Combining AI and scientific expertise

Prezent Vivo is designed to help pharmaceutical, biotechnology, and other life sciences organizations develop scientific and commercial communications. Its platform combines purpose-built artificial intelligence with human expertise to produce materials that require scientific accuracy, regulatory awareness, and consistency with corporate brand guidelines.

The solution supports the development of scientific posters, data visualizations, medical documents, brochures, Medical Science Liaison (MSL) materials, advisory board content, and sales meeting communications.

At the center of its AI capabilities is Astrid, an agent designed specifically for life sciences communication. According to the company, the technology is built to account for regulatory language, clinical evidence structures, brand requirements, and medical and commercial strategies.

Prezent Vivo also incorporates specialists, including medical writers and communication experts, who provide scientific judgment and editorial oversight. This approach seeks to address a limitation of general-purpose AI tools: generating content quickly does not necessarily guarantee the scientific precision or regulatory context required in pharmaceutical communications.

The platform offers three main engagement models: a self-service AI environment, overnight communication services, and fixed-price projects for more complex requirements.

A growing role for AI in life sciences

The recognition comes as AI adoption expands across the biotechnology and pharmaceutical industries, where companies are exploring applications in research, drug development, clinical operations, and commercial communications.

According to Prezent, more than 150 life sciences companies use its solutions, including 45 of the world’s top 50 biopharmaceutical organizations. The company has also expanded its offering through Prezent Vivo, targeting specialized communication requirements throughout the product lifecycle.

For the industry, the challenge is not simply generating scientific content faster. Organizations must also ensure that information remains accurate, understandable, and appropriate for its intended audience.

Recognition through the BioTech Breakthrough Awards places Prezent Vivo among the technologies receiving attention in a sector where AI is increasingly being applied to specialized workflows. Its approach reflects a broader development in enterprise technology: combining automation with domain-specific knowledge and human oversight to address tasks where accuracy and context remain essential.

Prezent Vivo receives recognition at the 2026 BioTech Breakthrough Awards
First Post Prezent Vivo receives recognition at the 2026 BioTech Breakthrough Awards
Publishers need tighter control over the path from ad booking to campaign delivery
Next Post Publishers need tighter control over the path from ad booking to campaign delivery
Related Posts

Leave a Comment: